 A TWO-DIMENSIONAL DOSE-FINDING STUDY OF IXAZOMIB IN COMBINATION WITH GEMCITABINE AND DOXORUBICIN, FOLLOWED BY A PHASE II EXTENSION TO ASSESS THE EFFICACY OF THIS COMBINATION IN METASTATIC, SURGICALLY UNRESECTABLE UROTHELIAL CANCER: 